Veradigm (NASDAQ:MDRX) Stock Price Down 12.2% – Here’s Why

Veradigm Inc. (NASDAQ:MDRX) was down 12.2% during mid-day trading on Friday . The stock traded as low as $4.30 and last traded at $4.30. Approximately 654 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 172,133 shares. The stock had previously closed at $4.90.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded shares of Veradigm to a “hold” rating in a research report on Saturday, March 7th.

Veradigm Stock Performance

The business’s 50 day moving average price is $4.59 and its 200-day moving average price is $4.65. The firm has a market capitalization of $517.72 million, a PE ratio of 23.25 and a beta of 0.52.

Veradigm Company Profile

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.